Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

623-886 (Protein kinase domain)

Relief mechanism

PTM

Assay

Accessory elements

765-793 (Activation loop from InterPro)

Target domain

624-882 (Serine-threonine/tyrosine-protein kinase, catalytic domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for Q07498

Entry ID Method Resolution Chain Position Source
AF-Q07498-F1 Predicted AlphaFoldDB

No variants for Q07498

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q07498

2 associated diseases with Q07498

[MIM: 264800]: Pseudoxanthoma elasticum (PXE)

A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. {ECO:0000269|PubMed:10811882, ECO:0000269|PubMed:10835642, ECO:0000269|PubMed:10954200, ECO:0000269|PubMed:11427982, ECO:0000269|PubMed:11536079, ECO:0000269|PubMed:11702217, ECO:0000269|PubMed:11880368, ECO:0000269|PubMed:15086542, ECO:0000269|PubMed:15098239, ECO:0000269|PubMed:15459974, ECO:0000269|PubMed:16086317, ECO:0000269|PubMed:17617515, ECO:0000269|PubMed:19339160, ECO:0000269|PubMed:20034067, ECO:0000269|PubMed:24277820, ECO:0000269|PubMed:25615550, ECO:0000269|PubMed:30154241}. Note=The disease is caused by variants affecting the gene represented in this entry. Homozygous or compound heterozygous ABCC6 mutations have been found in the overwhelming majority of cases. Individuals carrying heterozygous mutations express limited manifestations of the pseudoxanthoma elasticum phenotype.

[MIM: 614473]: Arterial calcification of infancy, generalized, 2 (GACI2)

A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. {ECO:0000269|PubMed:22209248}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. {ECO:0000269|PubMed:10811882, ECO:0000269|PubMed:10835642, ECO:0000269|PubMed:10954200, ECO:0000269|PubMed:11427982, ECO:0000269|PubMed:11536079, ECO:0000269|PubMed:11702217, ECO:0000269|PubMed:11880368, ECO:0000269|PubMed:15086542, ECO:0000269|PubMed:15098239, ECO:0000269|PubMed:15459974, ECO:0000269|PubMed:16086317, ECO:0000269|PubMed:17617515, ECO:0000269|PubMed:19339160, ECO:0000269|PubMed:20034067, ECO:0000269|PubMed:24277820, ECO:0000269|PubMed:25615550, ECO:0000269|PubMed:30154241}. Note=The disease is caused by variants affecting the gene represented in this entry. Homozygous or compound heterozygous ABCC6 mutations have been found in the overwhelming majority of cases. Individuals carrying heterozygous mutations express limited manifestations of the pseudoxanthoma elasticum phenotype.
  • A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. {ECO:0000269|PubMed:22209248}. Note=The disease is caused by variants affecting the gene represented in this entry.

2 regional properties for Q07498

Type Name Position InterPro Accession
domain Kinesin motor domain 3 - 343 IPR001752
conserved_site Kinesin motor domain, conserved site 234 - 245 IPR019821

Functions

Description
EC Number 4.6.1.2 Phosphorus-oxygen lyases
Subcellular Localization
  • Cell membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
dendrite A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ephrin receptor activity Combining with an ephrin receptor ligand to initiate a change in cell activity.
transmembrane-ephrin receptor activity Combining with a transmembrane ephrin to initiate a change in cell activity.

12 GO annotations of biological process

Name Definition
axon guidance The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
axonal fasciculation The collection of axons into a bundle of rods, known as a fascicle.
cell migration The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues.
dendritic spine development The process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
dendritic spine morphogenesis The process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
ephrin receptor signaling pathway The series of molecular signals initiated by ephrin binding to its receptor, and ending with the regulation of a downstream cellular process, e.g. transcription.
positive regulation of synapse assembly Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
protein autophosphorylation The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
regulation of axonogenesis Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron.
regulation of cell-cell adhesion Any process that modulates the frequency, rate or extent of attachment of a cell to another cell.
regulation of GTPase activity Any process that modulates the rate of GTP hydrolysis by a GTPase.
substrate adhesion-dependent cell spreading The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.

52 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q07494 EPHB1 Ephrin type-B receptor 1 Gallus gallus (Chicken) SS
O42422 EPHA7 Ephrin type-A receptor 7 Gallus gallus (Chicken) SS
P28693 EPHB2 Ephrin type-B receptor 2 Gallus gallus (Chicken) PR
P29318 EPHA3 Ephrin type-A receptor 3 Gallus gallus (Chicken) SS
P54755 EPHA5 Ephrin type-A receptor 5 Gallus gallus (Chicken) SS
Q07496 EPHA4 Ephrin type-A receptor 4 Gallus gallus (Chicken) SS
Q07497 EPHB5 Ephrin type-B receptor 5 Gallus gallus (Chicken) PR
P0C0K6 EPHB6 Ephrin type-B receptor 6 Pan troglodytes (Chimpanzee) SS
P29322 EPHA8 Ephrin type-A receptor 8 Homo sapiens (Human) SS
P21709 EPHA1 Ephrin type-A receptor 1 Homo sapiens (Human) SS
P54764 EPHA4 Ephrin type-A receptor 4 Homo sapiens (Human) SS
P29320 EPHA3 Ephrin type-A receptor 3 Homo sapiens (Human) PR
P54760 EPHB4 Ephrin type-B receptor 4 Homo sapiens (Human) SS
P29317 EPHA2 Ephrin type-A receptor 2 Homo sapiens (Human) SS
Q15375 EPHA7 Ephrin type-A receptor 7 Homo sapiens (Human) SS
Q5JZY3 EPHA10 Ephrin type-A receptor 10 Homo sapiens (Human) SS
P29323 EPHB2 Ephrin type-B receptor 2 Homo sapiens (Human) EV
Q9UF33 EPHA6 Ephrin type-A receptor 6 Homo sapiens (Human) SS
P54762 EPHB1 Ephrin type-B receptor 1 Homo sapiens (Human) SS
P54756 EPHA5 Ephrin type-A receptor 5 Homo sapiens (Human) SS
O15197 EPHB6 Ephrin type-B receptor 6 Homo sapiens (Human) SS
P54753 EPHB3 Ephrin type-B receptor 3 Homo sapiens (Human) SS
Q03145 Epha2 Ephrin type-A receptor 2 Mus musculus (Mouse) PR
Q03137 Epha4 Ephrin type-A receptor 4 Mus musculus (Mouse) SS
Q61772 Epha7 Ephrin type-A receptor 7 Mus musculus (Mouse) SS
O09127 Epha8 Ephrin type-A receptor 8 Mus musculus (Mouse) SS
Q8CBF3 Ephb1 Ephrin type-B receptor 1 Mus musculus (Mouse) SS
Q8BYG9 Epha10 Ephrin type-A receptor 10 Mus musculus (Mouse) SS
Q60629 Epha5 Ephrin type-A receptor 5 Mus musculus (Mouse) SS
P29319 Epha3 Ephrin type-A receptor 3 Mus musculus (Mouse) SS
Q62413 Epha6 Ephrin type-A receptor 6 Mus musculus (Mouse) SS
Q60750 Epha1 Ephrin type-A receptor 1 Mus musculus (Mouse) SS
P54763 Ephb2 Ephrin type-B receptor 2 Mus musculus (Mouse) SS
P54761 Ephb4 Ephrin type-B receptor 4 Mus musculus (Mouse) PR
O08644 Ephb6 Ephrin type-B receptor 6 Mus musculus (Mouse) PR
P54754 Ephb3 Ephrin type-B receptor 3 Mus musculus (Mouse) SS
P54757 Epha5 Ephrin type-A receptor 5 Rattus norvegicus (Rat) SS
P54759 Epha7 Ephrin type-A receptor 7 Rattus norvegicus (Rat) SS
P09759 Ephb1 Ephrin type-B receptor 1 Rattus norvegicus (Rat) SS
P0C0K7 Ephb6 Ephrin type-B receptor 6 Rattus norvegicus (Rat) SS
O08680 Epha3 Ephrin type-A receptor 3 Rattus norvegicus (Rat) SS
O61460 vab-1 Ephrin receptor 1 Caenorhabditis elegans SS
Q7X8C5 WAKL2 Wall-associated receptor kinase-like 2 Arabidopsis thaliana (Mouse-ear cress) PR
Q9S9M2 WAKL4 Wall-associated receptor kinase-like 4 Arabidopsis thaliana (Mouse-ear cress) PR
Q9LMN7 WAK5 Wall-associated receptor kinase 5 Arabidopsis thaliana (Mouse-ear cress) PR
Q9C9L5 WAKL9 Wall-associated receptor kinase-like 9 Arabidopsis thaliana (Mouse-ear cress) PR
Q8VYA3 WAKL10 Wall-associated receptor kinase-like 10 Arabidopsis thaliana (Mouse-ear cress) PR
Q9M092 WAKL17 Wall-associated receptor kinase-like 17 Arabidopsis thaliana (Mouse-ear cress) PR
Q0WNY5 WAKL18 Wall-associated receptor kinase-like 18 Arabidopsis thaliana (Mouse-ear cress) PR
O73878 ephb4b Ephrin type-B receptor 4b Danio rerio (Zebrafish) (Brachydanio rerio) SS
O13146 epha3 Ephrin type-A receptor 3 Danio rerio (Zebrafish) (Brachydanio rerio) SS
O13147 ephb3 Ephrin type-B receptor 3 Danio rerio (Zebrafish) (Brachydanio rerio) SS
10 20 30 40 50 60
MVSSILKFVI LIHSTFHSTF AQNLPDTTVA PKTKRTIKIG IAAAQRTQTS SIGWSVCGGA
70 80 90 100 110 120
VPMAIERLRE FGYVKDFDFE FIVDYTECDQ GSVVRAGIEF IKTHKVDVII GPPCAQALRV
130 140 150 160 170 180
MSFLAENYKK PVLGWGFVSD TDLSDVIRFP YLTTVIPNSL MLGYAASKML TVYNWGRVAM
190 200 210 220 230 240
LYYYSDIKYC SGVMNDVEAT FNNPSTPNVN IVIKAEIYLN DNETTDIVFQ SVKSRARIIF
250 260 270 280 290 300
WCTQTAIEKR DYLIKIATHD MIGDEYVHIM LSMRNIAFGA QTSLGKPTFS QSGLTPIWES
310 320 330 340 350 360
FTEGTDDFEK MVKQAATRMF VLDVNSEVAD KKYLDYLQKN IMKAVQSPPM NCSTVECMTA
370 380 390 400 410 420
NTTIMGGYAR QLFDVVYLYG VALTNTNSTD PAVYDDVDVI VPQFVTSFQG MTGKVVISPN
430 440 450 460 470 480
LTRMPIFQLY GLNSDYEQVA LAEFTYIDPI MNVTLSYKEE GGAVWYFYGN SRPLDIPICG
490 500 510 520 530 540
FLGKFCPISF WEQYMILAIV SISVIVLMVI IMIIGCLCVI SAKHAEQART NAEWQVPFVN
550 560 570 580 590 600
LMESEKQIRS NATSRRSLQS APSISTGHSG VTTVSDFCEN YTMMMYEKEM VLTAKYQYTH
610 620 630 640 650 660
LTKADKERFV KMRKLDHENI NRFIGLSIDS AHFIAVTKLC SRGSLQDILS RGNFSMDYFF
670 680 690 700 710 720
MFCIIRDVAK GLEYLHKTFL RLHGNLRSAT CLVNDSWQVK LAEYGMDNLV EEQTPPKKRL
730 740 750 760 770 780
LWVAPEVLRG SLSVSQMEPS ADIYSFAIIA SEILTKKEAW DILDRKEDCE ALIALVKDCW
790 800 810 820 830 840
AEVPEDRPTA ENICSQMKGL VSKQKTNLMD HVFNMLEEYT STLEEEIEER TKELTLEKKK
850 860 870 880 890 900
ADILLSRMLP KQVAERLKAG QTVEPEGFDS VTVFFSDVVK FTILASKCSP FQTVNLLNDL
910 920 930 940 950 960
YSNFDTIIEQ HGVYKVESIG DGYLCVSGLP TRNGYAHIKQ IVDMSLKFME YCRSFKIPHL
970 980 990 1000 1010 1020
PRENVELRIG VNSGPCVAGV VGLSMPRYCL FGDTVNTASR MESNGKPSLI HLTSDAHLLL
1030 1040 1050 1060 1070 1080
LTHYPNHYDT SSRGEVIIKG KGVMETFWVH GRIDDIAEPT ELRSICKPST VANERWITPP
1090 1100 1110
APKPEIRSVS SHGSRPPSVY DPLQDHRKFK MDTLKVAN